These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30670791)

  • 1. Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma.
    Konduri V; Halpert MM; Baig YC; Coronado R; Rodgers JR; Levitt JM; Cerroni B; Piscoya S; Wilson N; DiBernardi L; Omarbekov Z; Seelhoff L; Ravi V; Douglass L; Decker WK
    Cancer Gene Ther; 2019 Sep; 26(9-10):282-291. PubMed ID: 30670791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
    Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
    PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
    J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
    Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
    J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy - a prospective, randomized double-blind study].
    Reck A; Gedon J; Kessler M
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Dec; 51(6):394-402. PubMed ID: 38056478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
    Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
    BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
    Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F
    J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen.
    Gyorffy S; Rodriguez-Lecompte JC; Woods JP; Foley R; Kruth S; Liaw PC; Gauldie J
    J Vet Intern Med; 2005; 19(1):56-63. PubMed ID: 15715049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
    Gedney A; Salah P; Mahoney JA; Krick E; Martins R; Scavello H; Lenz JA; Atherton MJ
    Vet Comp Oncol; 2022 Sep; 20(3):688-696. PubMed ID: 35442554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
    Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
    Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.
    Mason NJ; Gnanandarajah JS; Engiles JB; Gray F; Laughlin D; Gaurnier-Hausser A; Wallecha A; Huebner M; Paterson Y
    Clin Cancer Res; 2016 Sep; 22(17):4380-90. PubMed ID: 26994144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
    Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
    Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
    Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma.
    Locke JE; Barber LG
    J Vet Intern Med; 2006; 20(4):962-7. PubMed ID: 16955823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
    Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemangiosarcoma in dogs and cats.
    Smith AN
    Vet Clin North Am Small Anim Pract; 2003 May; 33(3):533-52, vi. PubMed ID: 12852235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
    Finotello R; Stefanello D; Zini E; Marconato L
    Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.